Prediction of Mild Cognitive Impairment Conversion Using a Combination of Independent Component Analysis and the Cox Model

Mild cognitive impairment (MCI) represents a transitional stage from normal aging to Alzheimer’s disease (AD) and corresponds to a higher risk of developing AD. Thus, it is necessary to explore and predict the onset of AD in MCI stage. In this study, we propose a combination of independent component analysis (ICA) and the multivariate Cox proportional hazards regression model to investigate promising risk factors associated with MCI conversion among 126 MCI converters and 108 MCI non-converters from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. Using structural magnetic resonance imaging (MRI) and fluorodeoxyglucose positron emission tomography (FDG-PET) data, we extracted brain networks from AD and normal control groups via ICA and then constructed Cox models that included network-based neuroimaging factors for the MCI group. We carried out five separate Cox analyses and the two-modality neuroimaging Cox model identified three significant network-based risk factors with higher prediction performance (accuracy = 73.50%) than those in either single-modality model (accuracy = 68.80%). Additionally, the results of the comprehensive Cox model, including significant neuroimaging factors and clinical variables, demonstrated that MCI individuals with reduced gray matter volume in a temporal lobe-related network of structural MRI [hazard ratio (HR) = 8.29E-05 (95% confidence interval (CI), 5.10E- 07 ~ 0.013)], low glucose metabolism in the posterior default mode network based on FDG-PET [HR = 0.066 (95% CI, 4.63E-03 ~ 0.928)], positive apolipoprotein E ε4-status [HR = 1. 988 (95% CI, 1.531 ~ 2.581)], increased Alzheimer’s Disease Assessment Scale-Cognitive Subscale scores [HR = 1.100 (95% CI, 1.059 ~ 1.144)] and Sum of Boxes of Clinical Dementia Rating scores [HR = 1.622 (95% CI, 1.364 ~ 1.930)] were more likely to convert to AD within 36 months after baselines. These significant risk factors in such comprehensive Cox model had the best prediction ability (accuracy = 84.62%, sensitivity = 86.51%, specificity = 82.41%) compared to either neuroimaging factors or clinical variables alone. These results suggested that a combination of ICA and Cox model analyses could be used successfully in survival analysis and provide a network-based perspective of MCI progression or AD-related studies.

[1]  T. Adali,et al.  A feature-based approach to combine functional MRI, structural MRI and EEG brain imaging data , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[2]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[3]  C. Jack,et al.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.

[4]  F. Jessen,et al.  AD dementia risk in late MCI, in early MCI, and in subjective memory impairment , 2014, Alzheimer's & Dementia.

[5]  Clare E. Mackay,et al.  The effects of APOE on the functional architecture of the resting brain , 2012, NeuroImage.

[6]  Paul M. Thompson,et al.  Characterizing Alzheimer's disease using a hypometabolic convergence index , 2011, NeuroImage.

[7]  Bradford C. Dickerson,et al.  Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau , 2013, Front. Aging Neurosci..

[8]  L. Esserman,et al.  MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. , 2005, AJR. American journal of roentgenology.

[9]  V. Calhoun,et al.  Source‐based morphometry: The use of independent component analysis to identify gray matter differences with application to schizophrenia , 2009, Human brain mapping.

[10]  S. Leurgans,et al.  The neuropathology of probable Alzheimer disease and mild cognitive impairment , 2009, Annals of neurology.

[11]  David S Knopman,et al.  Classification and epidemiology of MCI. , 2013, Clinics in geriatric medicine.

[12]  Harald Hampel,et al.  Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease , 2012, Neurobiology of Aging.

[13]  James T Becker,et al.  Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.

[14]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[15]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[16]  M. Weiner,et al.  Automated MRI measures predict progression to Alzheimer's disease , 2010, Neurobiology of Aging.

[17]  D. Harvey,et al.  MCI is Associated With Deficits in Everyday Functioning , 2006, Alzheimer disease and associated disorders.

[18]  R. V. Van Heertum,et al.  Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18 F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls , 2010, Journal of geriatric psychiatry and neurology.

[19]  C. Jack,et al.  Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. , 2004, Archives of neurology.

[20]  Bradford C. Dickerson,et al.  Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: Insights from functional MRI studies , 2008, Neuropsychologia.

[21]  Bruno Vellas,et al.  Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer’s disease clinical trials , 2013, Alzheimer's & Dementia.

[22]  Stephen M. Smith,et al.  Investigations into resting-state connectivity using independent component analysis , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[23]  C. Jack,et al.  APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern , 2015, Alzheimer's & Dementia.

[24]  R. Peterson,et al.  Mild cognitive impairment: Transition from aging to Alzheimer's disease , 2000, Neurobiology of Aging.

[25]  G. Frisoni,et al.  MRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up study , 2008, Neurobiology of Aging.

[26]  Clifford R. Jack,et al.  Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD , 2011, NeuroImage.

[27]  Li Min Li,et al.  Voxel-based morphometry in patients with idiopathic generalized epilepsies , 2006, NeuroImage.

[28]  A. Dale,et al.  Building memories: remembering and forgetting of verbal experiences as predicted by brain activity. , 1998, Science.

[29]  M. Corbetta,et al.  Electrophysiological signatures of resting state networks in the human brain , 2007, Proceedings of the National Academy of Sciences.

[30]  M. Prince,et al.  World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends , 2015 .

[31]  Nick C. Fox,et al.  Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease , 2004, NeuroImage.

[32]  Jagath C. Rajapakse,et al.  Statistical approach to segmentation of single-channel cerebral MR images , 1997, IEEE Transactions on Medical Imaging.

[33]  Alan C. Evans,et al.  Fast and robust parameter estimation for statistical partial volume models in brain MRI , 2004, NeuroImage.

[34]  H. Rusinek,et al.  Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[35]  F. Yetkin,et al.  FMRI of working memory in patients with mild cognitive impairment and probable Alzheimer’s disease , 2005, European Radiology.

[36]  Rex E. Jung,et al.  Neuroinformatics Original Research Article Correspondence between Structure and Function in the Human Brain at Rest , 2022 .

[37]  Y. Yuan,et al.  Fluorodeoxyglucose–Positron-Emission Tomography, Single-Photon Emission Tomography, and Structural MR Imaging for Prediction of Rapid Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis , 2008, American Journal of Neuroradiology.

[38]  M. Angermeyer,et al.  Mild cognitive impairment 1 – a review of prevalence, incidence and outcome according to current approaches , 2002, Acta psychiatrica Scandinavica.

[39]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[40]  Daoqiang Zhang,et al.  Identification of MCI individuals using structural and functional connectivity networks , 2012, NeuroImage.

[41]  John C. Morris,et al.  Progression of Alzheimer’s disease as measured by Clinical Dementia Rating Sum of Boxes scores , 2013, Alzheimer's & Dementia.

[42]  Chunshui Yu,et al.  Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta‐analyses of MRI studies , 2009, Hippocampus.

[43]  M Filippi,et al.  Voxel‐based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability , 2007, Human brain mapping.

[44]  Marilyn Albert,et al.  Variation in Variables that Predict Progression from MCI to AD Dementia over Duration of Follow-up. , 2013, American journal of Alzheimer's disease.

[45]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .

[46]  Frederik Barkhof,et al.  Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study , 2010, Neurobiology of Aging.

[47]  Erkki Oja,et al.  Independent component analysis: algorithms and applications , 2000, Neural Networks.

[48]  Kathryn Ziegler-Graham,et al.  Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[49]  G. Frisoni,et al.  Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[50]  R. Kay The Analysis of Survival Data , 2012 .

[51]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[52]  A. Monsch,et al.  Serial position effects are sensitive predictors of conversion from MCI to Alzheimer's disease dementia , 2014, Alzheimer's & Dementia.

[53]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[54]  J. Dartigues,et al.  Alzheimer's disease: a global challenge for the 21st century , 2009, The Lancet Neurology.

[55]  A. D'Amico,et al.  Combination of the preoperative PSA level, biopsy gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer. , 2000, Urology.

[56]  Christos Davatzikos,et al.  Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI , 2009, NeuroImage.

[57]  W. Jagust,et al.  The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core , 2010, Alzheimer's & Dementia.

[58]  Pierrick Coupé,et al.  Author manuscript, published in "Journal of Magnetic Resonance Imaging 2010;31(1):192-203" DOI: 10.1002/jmri.22003 Adaptive Non-Local Means Denoising of MR Images with Spatially Varying Noise Levels , 2010 .

[59]  D.,et al.  Regression Models and Life-Tables , 2022 .

[60]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[61]  Heikki Huttunen,et al.  Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects , 2015, NeuroImage.

[62]  Jun Liu,et al.  MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease , 2012, NeuroImage.

[63]  S. Rombouts,et al.  Associations between age and gray matter volume in anatomical brain networks in middle-aged to older adults , 2014, Aging Cell.

[64]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[65]  Vince D. Calhoun,et al.  Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer's Disease: An Independent Component Analysis , 2006, The Journal of Neuroscience.

[66]  R. Mayeux,et al.  Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.

[67]  W. Jagust,et al.  Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series , 2013, Alzheimer's & Dementia.

[68]  P. Murali Doraiswamy,et al.  Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth , 2013, NeuroImage.